Cardiovascular risk factors and models of risk prediction: Recognizing the leadership of Dr Roy Dawber

British Columbia Medical Journal

Volumn 52, Issue 7, 2010, Pages 342-348

  Davis, Margot ^a   Andrade, Jason ^a   Taylor, Carolyn ^a   Ignaszewski, Andrew ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957745322     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Framingham Heart Study. www.framinghamheartstudy.org/ (accessed 30 July 2009)
2. Kannel W, Dawber T, Kagan A, et al. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 1961;55:33-50.
3. Doyle JT, Dawber TR, Kannel WB, et al. Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med 1962;26:796-801.
4. Mann GV, Pearson G, Gordon T, et al. Diet and cardiovascular disease in the Framingham study. I. Measurement of dietary intake. Am J Clin Nutr 1962; 11:200-225.
5. Kannel WB, Dawber TR, Thomas HE, Jr, et al. Comparison of serum lipids in the prediction of coronary heart disease. Framingham Study indicates that cholesterol level and blood pressure are major factors in coronary heart disease; effect of obesity and cigarette smoking also noted. R I Med J 1965;48:243-250.
6. Dawber TR, Kannel WB, McNamara PM, et al. An epidemiologic study of apoplexy ("strokes"). Observations in 5,209 adults in the Framingham Study on Association of Various Factors in the Development of Apoplexy. Trans Am Neurol Assoc 1965;90:237-240.
7. Vander JB, Gaston EA, Dawber TR. Significance of solitary nontoxic thyroid nodules; preliminary report. N Engl J Med 1954;251:970-973.
8. Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: Observations in the Framingham Study. J Chronic Dis 1966;19:273-292.
9. Hall AP, Barry PE, Dawber TR, et al. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 1967;42:27-37.
10. Dawber TR. Identification of excess cardiovascular risk. A practical approach. Minn Med 1969;52:1217-1221.
11. Dawber TR, Thomas HE, Jr. Prevention of myocardial infarction. Prog Cardiovasc Dis 1971;13:343-360.
12. Wilson P, D'Agostino R, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
13. Eichler K, Puhan MA, Steurer J, et al. Prediction of first coronary events with the Framingham score: A systematic review. Am Heart J 2007;153:722-731.
14. Eyre H, Kahn R, Robertson RM, et al. Preventing cancer, cardiovascular disease, and diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 2004;109:3244-3255.
15. D'Agostino RBS, Grundy S, Sullivan LM, et al; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001;286:180-187.
16. Aarabi M, Jackson PR. Coronary risk in South Asians: Role of ethnicity and blood sugar. Eur J Cardiovasc Prev Rehabil 2004;11:389-393.
17. Aarabi M, Jackson PR. Predicting coronary risk in UK South Asians: An adjustment method for Framingham-based tools. Eur J Cardiovasc Prev Rehabil. 2005;12:446-451.
18. Brindle P, May M, Gill P, et al. Primary prevention of cardiovascular disease: A web-based risk score for seven British black and minority ethnic groups. Heart 2006;92:1595-1602.
19. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA. 2007;297:611-619.
20. Ridker P, Paynter N, Rifai N, et al. Creactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men. Circulation. 2008;118:2243-2251
21. Wilson P, Pencina M, Jacques P, et al. C-reactive protein and reclassification of cardiovascular risk in the ramingham Heart Study. Circ Cardiovasc Qual Outcomes 2008;1:92-97.
22. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study. BMJ 2007;335:136.
23. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. BMJ. 2008;336:1475-1482.
24. Mosca L, Ferris A, Fabunmi R, et al. Tracking women's awareness of heart disease: An American Heart Association national study. Circulation 2004; 109:573-579.
25. Pencina M, D'Agostino R, Larson M, et al. Predicting the 30-year risk of cardiovascular disease: The Framingham Heart Study. Circulation 2009;119: 3078-3084.
26. Lloyd-Jones D. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation.2006;113:791-798.
27. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2-therapy. Can J Cardiol 2008; 24:465-475.